Research and Markets has announced the addition of the "Drugs and Diagnostics for Hematological Disorders: Global Markets" report to their offering.
The global market for hematology drugs and diagnostics is expected to grow from nearly $86.5 billion in 2015 to $124.3 billion in 2020 at a compound annual growth rate of 7.5% from 2015-2020.
This report provides:
The report also discusses the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends, and clinical and new developments.
Companies Mentioned Include:
3: Hematalogical Disorders
4: Hematological Cancers
7: Multiple Myeloma
8: Myelodysplastic Syndromes
9: Myeloproliferative Disorders
10: Epidemiology Of Hematological Cancers
11: Hematology Instruments And Reagents: A Global Market Perspective
12: Global Market For Treatments For Hematological Disorders
13: Hematological Cancer Therapies Market
14: Patent Landscape And Current Developments
15: Selected Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/t5dvdw/drugs_and
View source version on businesswire.com: http://www.businesswire.com/news/home/20160930005326/en/Business Wire
Last updated on: 30/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.